Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus

Immunity

Volumn 21, Issue 2, 2004, Pages 215-226

  Tsuda, Yasuhiro ^a   Takahashi, Hitoshi ^a   Kobayashi, Makiko ^a,b   Hanafusa, Toshiaki ^c   Herndon, David N ^b   Suzuki, Fujio ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; CD11B ANTIGEN; CHEMOKINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MEMBRANE ANTIGEN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOST PATHOGEN INTERACTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MACROPHAGE ACTIVATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NEUTROPHIL; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL DIFFERENTIATION; DISEASE SUSCEPTIBILITY; IMMUNITY, NATURAL; MACROPHAGES; METHICILLIN; METHICILLIN RESISTANCE; MICE; MICE, SCID; NEUTROPHIL ACTIVATION; NEUTROPHILS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 4143115478     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2004.07.006     Document Type: Article

References (41)

1. Aderem A., Underhill D.M. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17:1999;593-623
2. Bone R.C. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit. Care Med. 24:1996;1125-1128
3. Brandt E., Woerly G., Younes A.B., Loiseau S., Capron M. IL-4 production by human polymorphonuclear neutrophils. J. Leukoc. Biol. 68:2000;125-130
4. Brown C.C., Malech H.L., Jacobson R.J., Shrimpton C.F., Beverly P.C., Segal A.W., Gallin J.I. Unique human neutrophil populations are defined by monoclonal antibody ED12F8C10. Cell. Immunol. 132:1991;102-114
5. Byrne A., Reen D.J. Lipopolysaccharide induced rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils. J. Immunol. 168:2002;1968-1977
6. Chavakis T., Hussain M., Kanse S.M., Peters G., Bretzel R.G., Flock J.I., Herrmann M., Preissner K.T. Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat. Med. 8:2002;687-693
7. Czermak B.J., Sarma V., Pierson C.L., Warner R.L., Huber-Lang M., Bless N.M., Schmal H., Friedl H.P., Ward P.A. Protective effects of C5a blockade in sepsis. Nat. Med. 5:1999;788-792
8. Davey V. Immunocompromised persons and emerging infectious diseases. Lashley F.R., Durham J.D. Emerging Infectious Diseases. 2002;303-324 Springer Publishing Co., Inc, New York
9. Elgert K.D., Alleva D.G., Mullins D.W. Tumor-induced immune dysfunction. the macrophage connection J. Leukoc. Biol. 64:1998;275-290
10. Fan J., Malik A.B. Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors. Nat. Med. 9:2003;315-321
11. Furukawa K., Kobayashi M., Hendon D.N., Pollard R.B., Suzuki F. Appearance of monocyte chemoattractant protein-1 (MCP-1) early after thermal injury. role in the subsequent development of burn-associated type 2 T cell reposes Ann. Surg. 236:2002;112-119
12. + myeloid cells. J. Immunol. 166:2001;5398-5406
13. Gallin J.I. Human neutrophil heterogeneity exists, but is it meaningful? Blood. 63:1984;977-983
14. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 3:2003;23-35
15. Goerdt S., Orfanos C.E. Other functions, other genes. alternative activation of antigen-presenting cells Immunity. 10:1999;137-142
16. Gu L., Tseng S., Horner R.M., Tam C., Loda M., Rollins B.J. Control of Th2 polarizations by the chemokine monocyte chemoattractant protein-1. Nature. 404:2000;407-411
17. Haddadin A.S., Fappiano S.A., Lipsett P.A. Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad. Med. J. 78:2002;385-392
18. Hibbs J.B. Jr. Activated macrophages as cytotoxic effector cells. I. inhibition of specific and nonspecific tumor resistance by trypan blue Transplantation. 19:1975;77-81
19. Hickman S.P., Chan J., Salgame P. Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naïve T cell polarization. J. Immunol. 168:2002;4636-4642
20. Katakura T., Miyazaki M., Kobayashi M., Herndon D.N., Suzuki F. CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophage. J. Immunol. 172:2004;1407-1413
21. Krause P.J., Malech H.L., Kristie J., Kosciol C.M., Herson V.C., Eisenfeld L., Pastuszak W.T., Kraus A., Seligmann B. Polymorphonuclear leukocyte heterogeneity in neonates and adults. Blood. 68:1986;200-204
22. Kristian S.A., Durr M., van Strijp J.A.G., Neumeister B., Peschel A. MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing. Infect. Immun. 71:2003;546-549
23. Kusmartsev S., Gabrilovich D.I. Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol. Immunother. 51:2002;293-298
24. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization. tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol. 23:2002;549-555
25. Magram J., Sfarra J., Connaughton S., Faherty D., Warrier R., Carvajal D., Wu C.Y., Stewart C., Sarmiento U., Gately M.K. IL-12-deficient mice are defective but not devoid of type 1 cytokine responses. Ann. NY Acad. Sci. 795:1996;60-70
26. Malawista S.E., Montgomery R.R., van Blaricom G. Microbial killing by human neutrophil cytokineplasts. similar suppressive effects of reversible and irreversible inhibitors of nitric oxide synthase J. Leukoc. Biol. 60:1996;753-757
27. + myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J. Immunol. 169:2002;3180-3190
28. Mills C.D., Kincaid K., Alt J.M., Heilman M.J., Hill A.M. M-1/M-2 macrophage and Th1/Th2 paradigm. J. Immunol. 164:2000;6166-6173
29. Mocsai A., Zhang H., Jakus Z., Kitaura J., Kawasaki T., Lowell C.A. G-protein-coupled receptor signaling in Syk-deficient neutrophils and mast cells. Blood. 101:2003;4155-4163
30. Romani L., Mencacci A., Cenci E., Spaccapelo R., Del Sero G., Nicoletti I., Trinchieri G., Bistoni F., Puccetti P. Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J. Immunol. 158:1997;5349-5356
31. Sabroe I., Prince L.R., Jones E.C., Horsburgh M.J., Foster S.J., Vogel S.N., Dower S.K., Whyte M.K. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J. Immunol. 170:2003;5268-5275
32. Sester D.P., Stacey K.J., Sweet M.J., Beasley S.J., Cronau S.L., Hume D.A. The actions of bacterial DNA on murine macrophages. J. Leukoc. Biol. 66:1999;542-548
33. Stein M., Keshav S., Harris N., Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity. a marker of alternative immunologic macrophage activation J. Exp. Med. 176:1992;287-292
34. Steinstraesser L., Fohn M., Klein R.D., Aminlari A., Remick D.G., Su G.L., Wang S.C. Feasibility of biolistic gene therapy in burns. Shock. 4:2001;272-277
35. Takahashi H., Tashiro T., Miyazaki M., Kobayashi M., Pollard R.B., Suzuki F. An essential role of macrophage inflammatory protein 1α/CCL3 on the expression of host's innate immunities against infectious complications. J. Leukoc. Biol. 72:2002;1190-1197
36. Taub D.D., Turcovski-Corrales S.M., Key M.L., Longo D.L., Murphy W.J. Chemokines and T lymphocyte activation. I. β chemokines costimulate human T lymphocyte activation in vitro J. Immunol. 156:1996;2095-2103
37. Ulevitch R.J. Toll gates for pathogen selection. Nature. 401:1999;755-756
38. Verhoef J. Host defense against infection. Crossley K.B., Archer G.L. The Staphylococci in Human Disease. 1997;213-232 Churchill Livingstone, Inc, New York
39. Yamashiro S., Kamohara H., Yoshimura T. MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils. TNF-α plays a role in maximal MCP-1 mRNA expression J. Leukoc. Biol. 65:1999;671-679
40. Yoshitake H., Takeda Y., Nitto T., Sendo F. Cross-linking of GPI-80, a possible regulatory molecule of cell adhesion, induces up-regulation of CD11b/CD18 expression on neutrophil surfaces and shedding of L-selectin. J. Leukoc. Biol. 71:2002;205-211
41. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 415:2002;389-395